DB:FJ3

Stock Analysis Report

Executive Summary

Fujimori Kogyo Co., Ltd. provides packaging materials, medical/pharmaceutical packaging materials, and materials for functional field in Japan.

Snowflake

Fundamentals

Flawless balance sheet and fair value.

Share Price & News

How has Fujimori Kogyo's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

4.4%

FJ3

3.9%

DE Chemicals

2.4%

DE Market


1 Year Return

7.0%

FJ3

-3.3%

DE Chemicals

4.9%

DE Market

Return vs Industry: FJ3 exceeded the German Chemicals industry which returned -3.3% over the past year.

Return vs Market: FJ3 exceeded the German Market which returned 4.9% over the past year.


Shareholder returns

FJ3IndustryMarket
7 Day4.4%3.9%2.4%
30 Day5.1%4.1%2.3%
90 Day20.3%2.8%2.7%
1 Year9.2%7.0%0.5%-3.3%8.2%4.9%
3 Year43.4%35.2%-1.9%-11.2%18.3%8.0%
5 Year52.5%37.1%25.6%6.4%44.2%24.6%

Price Volatility Vs. Market

How volatile is Fujimori Kogyo's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Fujimori Kogyo undervalued compared to its fair value and its price relative to the market?

11.23x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: FJ3 (€28.6) is trading above our estimate of fair value (€23.84)

Significantly Below Fair Value: FJ3 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: FJ3 is good value based on its PE Ratio (11.2x) compared to the Chemicals industry average (20.5x).

PE vs Market: FJ3 is good value based on its PE Ratio (11.2x) compared to the German market (19.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate FJ3's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: FJ3 is good value based on its PB Ratio (1x) compared to the DE Chemicals industry average (1.7x).


Next Steps

Future Growth

How is Fujimori Kogyo forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

12.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: FJ3's forecast earnings growth (12.1% per year) is above the savings rate (0.2%).

Earnings vs Market: FJ3's earnings (12.1% per year) are forecast to grow slower than the German market (12.8% per year).

High Growth Earnings: FJ3's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if FJ3's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if FJ3's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if FJ3's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Fujimori Kogyo performed over the past 5 years?

-1.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: FJ3's earnings have declined by -1.7% per year over the past 5 years.

Accelerating Growth: FJ3's earnings growth over the past year (11.9%) exceeds its 5-year average (-1.7% per year).

Earnings vs Industry: FJ3 earnings growth over the past year (11.9%) exceeded the Chemicals industry -5.5%.


Return on Equity

High ROE: FJ3's Return on Equity (9.2%) is considered low.


Return on Assets

ROA vs Industry: FJ3 has a higher Return on Assets than the Chemicals industry average last year.


Return on Capital Employed

ROCE Improving: FJ3's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Fujimori Kogyo's financial position?


Financial Position Analysis

Short Term Liabilities: FJ3's short term assets (¥69.6B) exceeds its short term liabilities (¥34.3B)

Long Term Liabilities: FJ3's short term assets (69.6B) exceeds its long term liabilities (6.2B)


Debt to Equity History and Analysis

Debt Level: FJ3's debt to equity ratio (4%) is considered satisfactory

Reducing Debt: FJ3's debt to equity ratio has reduced from 4.7% to 4% over the past 5 years.

Debt Coverage: FJ3's debt is well covered by operating cash flow (277.4%).

Interest Coverage: FJ3 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: FJ3 has a high level of physical assets or inventory.

Debt Coverage by Assets: FJ3's debt is covered by short term assets (assets are 25.892520x debt).


Next Steps

Dividend

What is Fujimori Kogyo's current dividend yield, its reliability and sustainability?

2.02%

Current Dividend Yield


Dividend Yield vs Market

company2.0%marketbottom25%1.5%markettop25%3.8%industryaverage4.0%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: FJ3's dividend (2.02%) is higher than the bottom 25% of dividend payers in the German market (1.46%).

High Dividend: FJ3's dividend (2.02%) is low compared to the top 25% of dividend payers in the German market (3.79%).

Stable Dividend: FJ3's dividend payments have been volatile in the past 10 years.

Growing Dividend: FJ3's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (21.4%), FJ3's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of Fujimori Kogyo's salary, the management and board of directors tenure and is there insider trading?

3.4yrs

Average management tenure


CEO

Eishi Fuyama (65yo)

6yrs

Tenure

0

Eishi Fuyama serves as President of Fujimori Kogyo Co., Ltd since October 2013 and served as General Manager of Life Science Business Division since April 2009 respectively and served as its Senior Managin ...


Management Age and Tenure

3.4yrs

Average Tenure

60yo

Average Age

Experienced Management: FJ3's management team is considered experienced (3.4 years average tenure).


Board Age and Tenure

5.7yrs

Average Tenure

65yo

Average Age

Experienced Board: FJ3's board of directors are considered experienced (5.7 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Eishi Fuyama (65yo)

    President & Representative Director

    • Tenure: 6yrs
  • Akijiro Yoshino (68yo)

    Managing Exec. Officer

    • Tenure: 11.3yrs
  • Kimihiko Shiomi (60yo)

    Managing Executive Officer & Director

    • Tenure: 7.3yrs
  • Hidenao Aoki

    Executive Officer

    • Tenure: 2.1yrs
  • Tetsuro Oe (57yo)

    Senior Executive Officer & Director

    • Tenure: 2.3yrs
  • Yasuharu Takada

    GM of Production Engineering Development Department & Executive Officer

    • Tenure: 3.4yrs
  • Hiroshi Komori (57yo)

    Executive Officer

    • Tenure: 0yrs
  • Hiroshi Saga (60yo)

    Senior Executive Officer

    • Tenure: 5.3yrs
  • Atsushi Takematsu

    GM of Functional Containers Division - Head Office of Life Science Business & Executive Officer

    • Tenure: 4yrs
  • Michihiko Sato

    Executive Officer & GM of Adhesive Materials Solution Division

    • Tenure: 3.3yrs

Board Members

  • Akihiko Fujimori (75yo)

    Chairman of the Board

    • Tenure: 6yrs
  • Eishi Fuyama (65yo)

    President & Representative Director

    • Tenure: 6yrs
  • Yukihiko Fujimori (70yo)

    Director

    • Tenure: 31.3yrs
  • Akijiro Yoshino (68yo)

    Managing Exec. Officer

    • Tenure: 11.3yrs
  • Nobuhiko Fujimori (60yo)

    Vice Chairman

    • Tenure: 5.3yrs
  • Kimihiko Shiomi (60yo)

    Managing Executive Officer & Director

    • Tenure: 7.3yrs
  • Tetsuro Oe (57yo)

    Senior Executive Officer & Director

    • Tenure: 2.3yrs
  • Hiroshi Saga (60yo)

    Senior Executive Officer

    • Tenure: 5.3yrs
  • Manabu Sakai

    Director

    • Tenure: 1.3yrs
  • Eizo Kobayashi (71yo)

    External Director

    • Tenure: 3.3yrs

Company Information

Fujimori Kogyo Co., Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Fujimori Kogyo Co., Ltd.
  • Ticker: FJ3
  • Exchange: DB
  • Founded: 1914
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Market Cap: JP¥65.947b
  • Listing Market Cap: JP¥545.268m
  • Shares outstanding: 19.03m
  • Website: https://www.zacros.co.jp

Number of Employees


Location

  • Fujimori Kogyo Co., Ltd.
  • Shinjuku First West
  • 10th Floor
  • Tokyo
  • 160-0023
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7917TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYDec 1993
FJ3DB (Deutsche Boerse AG)YesCommon SharesDEEURDec 1993

Biography

Fujimori Kogyo Co., Ltd. provides packaging materials, medical/pharmaceutical packaging materials, and materials for functional field in Japan. The company offers optoelectronic products, such as MASTACK T ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/21 21:25
End of Day Share Price2019/10/21 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.